Cancer Health Treatment Update
Tagrisso After Lung Cancer Surgery Cuts Risk of Death by Half

The oral targeted therapy led to a 51% improvement in survival for patients with EGFR-mutated non-small-cell lung cancer.

Clinical Trial Points to Treatment Advances for Brain Cancer
Vorasidenib prolonged progression free survival and delayed radiation and chemotherapy for IDH-mutant glioma.  
Personalized mRNA Vaccine Reduces Risk of Melanoma Spread

Moderna and Merck’s customized neoantigen vaccine plus Keytuda lowered the risk of metastasis or death by 65%.

News from ASCO 2023

See all our news from the American Society of Clinical Oncology annnual meeting, the world's largest cancer conference.

Advertisement
Cancer Health Spring 2023
Check out our latest print edition!
Cancer Health now offers individual newsletters for people interested in specific cancer types. Get the latest cancer news tailored to your needs and interests delivered to your inbox. To update your preferences and start getting cancer-specific newsletters, please visit your personal preferences page.
Toward a Definition of Long COVID

Defining symptoms will help identify participants for clinical trials to develop treatments for postacute sequelae of SARS-CoV-2.

More News About COVID-19
See all Cancer Health's coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com.

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2023 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.